Fuchs Endothelial Corneal Dystrophy clinical trials at UCLA
1 in progress, 0 open to eligible people
Showing trials for
K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)
Sorry, not currently recruiting here
A study to assess the safety and efficacy of K-321 in participants with FECD after descemetorhexis.
Los Angeles, California and other locations
Last updated: